GC-MS analysis detected 29 bioactive compounds in Thaumatococcus daniellii extracts, suggesting potential therapeutic benefits.
Plant extract have an immense capacity to synthesize secondary metabolites or phytochemicals which have pharmacological properties. They are generally regarded as safe, efficient and good alternative to replace antibiotic growth promoters and reduce environmental waste.The GCMS analysis of Thaumatococcus daniellii extracts (Table 1) identified 29 compounds representing 93.38 %. The dominant constituents in Thaumatococcus daniellii extracts are: Hexadecanoic acid (20.82 %), 4-Methyl Octane (13.81 %), 1,8-Cineole (12.72 %), Squalene (9.66 %), 13-Tetradece-11-yn-1-ol (9.44 %), α-Terpinolene (9.02 %) and β-Gurjunene (8.40 %). However, 2-Pentylfuran (0.01 %). Isophytol (0.02 %), Methyl nonanoate (0.06 %), α-Cedrene (0.07 %), β-Linalol (0.09 %), α-Ionone (0.12 %), Cis-7-Hexadecenal (0.12 %) amongst others are the minor compounds. Analysis of the chemical constituents based on the class of compounds revealed the presence of non-terpenes (53.18 %) followed by diterpenes (14.55 %), triterpenes (12.62 %), sesquiterpenes (8.72 %), apocarotenes (3.40 %) and monoterpenes (0.91 %). However, all these compounds can perform multiple biological activities including, anti-inflammatory, antioxidant, anti-tumor, immuno-stimulatory, gastro-protective, anti-helminthic, anti-diabetic amongst others
No takes yet. Share an insight, caveat, or question.
Alagbe John Olujimi (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: